Johnson & Johnson vs Teva Pharmaceutical Industries Limited
JNJ vs TEVA — side-by-side comparison from reported financials. JNJ leads 8, TEVA leads 2 of 10 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Teva Pharmaceutical Industries Limited
TEVA · Healthcare
$41.21+4.99%Strained
| Metric | JNJ | TEVA |
|---|---|---|
| Price | $261.79 | $41.21 |
| Market cap | $631B | $48.1B |
| Revenue (TTM) | $97.9B | $17.3B |
| Revenue growth | +5.6% | +5.0% |
| Net margin | 21.5% | 4.1% |
| Free cash flow | $22.2B | $1.35B |
| Net cash (debt) | ($27.8B) | $1.74B |
| 1-year price return | +37.0% | +105.6% |
| P/E | 29.9 | 63.2 |
| P/E vs own history (cheap-side %) | 16% | 0% |
| Dividend yield | 2.00% | — |
| Return on equity | 26% | 9% |
| Altman Z-score | — | 0.63 |
| CV checks passed | 10 of 11 | 7 of 11 |
| Employees | 140,800 | 32,842 |
Full résumé-style profiles: JNJ CV · TEVA CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.